Clinical Trial Update: Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for suvorexant assessing its effectiveness for sleep initiation and maintenance disorders in posttraumatic stress disorder; recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Post-traumatic Stress Disorder

Drugs mentioned

• Suvorexant (Belsomra) (suvorexant)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic | Phase 4 | Status: RECRUITING